The dependence receptor Ret induces apoptosis in somatotrophs through a Pit-1/p53 pathway, preventing tumor growth

Carmen Cañibano1, Noela L Rodriguez, Carmen Saez

  • 1Department of Physiology, School of Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain.

The EMBO Journal
|March 24, 2007
PubMed

Insights

Ret signaling in pituitary somatotrophs controls cell numbers by regulating Pit-1 (Pituitary homeobox 1) and p53. This pathway may offer new treatments for pituitary adenomas.

Area of Science:

  • Endocrinology
  • Cell Biology
  • Molecular Biology

Background:

  • Somatotrophs, the pituitary cells producing growth hormone, express Ret, GFRalpha1, and GDNF.
  • The precise role of Ret signaling in somatotroph regulation was not fully understood.

Purpose of the Study:

  • To investigate the function of Ret signaling in somatotroph cell number regulation.
  • To explore the therapeutic potential of targeting the Ret pathway in pituitary adenomas.

Main Methods:

  • Experiments were conducted using a somatotroph cell line, primary pituitary cultures, and Ret knockout (KO) mice.
  • Investigated the effects of Ret manipulation on Pit-1, p53, and apoptosis.
  • Utilized siRNA to block Ret or Pit-1, and retroviral gene transfer in vivo.

Main Results:

  • Ret signaling induces Pit-1 overexpression, leading to p53 expression and apoptosis, which can be blocked by Ret or Pit-1 siRNA.
  • The Ret/Pit-1 pathway involves PKCdelta, JNK, c/EBPalpha, and CREB activation; GDNF activates Akt, inhibiting apoptosis.
  • Ret KO mice exhibit pituitary hyperplasia, while Ret introduction inhibits tumor growth in vivo.

Conclusions:

  • Somatotrophs possess an intrinsic Ret-mediated apoptotic/survival pathway controlling Pit-1/Growth Hormone production.
  • Targeting the Ret pathway shows promise for treating pituitary adenomas.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...